Prediction and Discovery of Cannabidiol Crystal Polymorph Form 2.

Area of Science:

• Pharmaceutical Sciences
• Solid-State Chemistry

Background:

• Cannabidiol (CBD) is a non-psychoactive compound found in cannabis with significant therapeutic potential.
• Understanding the solid-state properties of CBD is crucial for developing stable and effective pharmaceutical formulations.
• Polymorphism, the ability of a solid material to exist in multiple crystalline forms, can significantly impact a drug's bioavailability and stability.

Purpose of the Study:

• To report and characterize the newly discovered crystal polymorph of cannabidiol, designated as Form 2.
• To provide a comprehensive understanding of the structural and physical properties of cannabidiol crystal polymorph Form 2.
• To discuss the implications of this discovery for future research and development of CBD-based therapeutics.

Main Methods:

• Single-crystal X-ray diffraction was employed to determine the molecular structure of Form 2.
• Powder X-ray diffraction (PXRD) was used for phase identification and purity assessment.
• Differential Scanning Calorimetry (DSC) and Thermogravimetric Analysis (TGA) were performed to evaluate thermal properties.
• Infrared (IR) spectroscopy and Raman spectroscopy were utilized for molecular vibrational analysis.

Main Results:

• The crystal structure of cannabidiol Form 2 was successfully elucidated, revealing unique intermolecular interactions.
• PXRD data confirmed the distinct crystalline nature of Form 2 compared to previously known polymorphs.
• Thermal analysis indicated differences in melting point and decomposition profile between Form 2 and other CBD forms.
• Spectroscopic analyses provided insights into the specific vibrational modes associated with the Form 2 crystal lattice.

Conclusions:

• The discovery of cannabidiol crystal polymorph Form 2 expands the known polymorphic landscape of CBD.
• Form 2 possesses distinct structural and physicochemical properties that warrant further investigation.
• This finding has potential implications for optimizing the formulation, manufacturing, and therapeutic efficacy of cannabidiol products.